Wnt Signalling in the Mouse Intestine

Total Page:16

File Type:pdf, Size:1020Kb

Wnt Signalling in the Mouse Intestine Oncogene (2006) 25, 7512–7521 & 2006 Nature Publishing Group All rights reserved 0950-9232/06 $30.00 www.nature.com/onc REVIEW Wnt signalling in the mouse intestine AR Clarke Cardiff School of Biosciences, Museum Avenue, Cardiff University, Cardiff, UK The ApcMin/ þ mouse has emerged as a powerful model of adenomatous polyposis (FAP), a human syndrome human intestinal tumour predisposition. As such, it has characterized by the development of multiple polyps in provided a platform for studying genetic and epigenetic the colon. In the mouse, genetic modelling of the modifiers of adenoma predisposition, and for assessing the involvement of the Wnt pathway was first made possible chemotherapeutic potential of a plethora of different by the creation of the ApcMin/ þ mouse, which emerged agents. The development of new conditional and hypo- out of an ethylnitrosourea mutagenesis programme and morphic Apc alleles, together with models carrying was subsequently characterized to carry a point muta- mutations in other Wnt pathway components, has greatly tion in the murine Apc gene (Su et al., 1992). The ApcMin/ þ extended the scope of experimentation. Together these mouse has proven to be a relatively good model of the approaches are being used to identify and validate key human FAP syndrome, and has been used extensively to critical targets of the Wnt pathway, such as Mash2, identify genetic and epigenetic modifiers of disease, as Tiam1 and the Eph/Ephrins. They have also established a well as to assess therapeutic regimens such as exposure fundamental role for Wnt in the development and to a range of different chemopreventatives. In recent maintenance of normal intestinal physiology, and in years this model has been joined by other Apc mutant particular control of the stem cell niche. These activities mice, both constitutive and conditional, and also by a are now being dissected at the level of individual Wnt cohort of models targeting different elements of the Wnt components, with some surprising dependencies revealed. pathway. These models have increasingly rationalized In terms of adenoma development, these models also our understanding of the role played by the Wnt support a ‘just right’ notion for tightly controlled b-catenin pathway in neoplasia, and are beginning to reveal the activity both in normal physiology and neoplastic develop- complex interplay that underlies normal intestinal ment. They also indicate a two-stage dependency for some physiology mechanisms as well as identifying putative Wnt pathway targets, with an initial requirement that novel disease markers and therapeutic targets. is subsequently overcome to permit progression. Finally, these models establish that the Wnt pathway does The ApcMin/ þ mouse not operate in isolation, and that both normal and diseased physiology develops in a dynamic interplay with Initially identified through the development of overt ApcMin/ þ other pathways such as the Notch, Hedgehog and BMP clinical symptoms of intestinal disease, the pathways. The comprehensive understanding arising from mouse carries a mutation at codon 850 and develops these studies should lead the identification of novel multiple small intestinal adenomas, in addition to a prognostic markers and therapeutic targets, and also open smaller number of colonic polyps. The prevalence of the possibility of tissue engineering in the intestine. small intestinal lesions represents one of the major Oncogene (2006) 25, 7512–7521. doi:10.1038/sj.onc.1210065 differences between the human syndrome and the mouse model, the explanation for which remains unclear. Keywords: Wnt;Apc;intestine The predisposition to intestinal polyposis also changes on different genetic backgrounds, a phenomenon which led to the identification of the first modifier of neoplasia, Mom-1 (Dietrich et al., 1993), subsequently identified as secretory phospholipase A2 (Pla2g2a, MacPhee et al., 1995). More recently other modifiers have been Introduction identified, including Mom-2 (Silverman et al., 2002) and a region on the distal arm of chromosome 18 (Haines Deregulation of the Wnt pathway is well recognized to et al., 2005). underpin the early stages of colorectal neoplasia in both As a relatively accurate genetic model of human the human and the mouse. This is perhaps most clearly disease, the ApcMin/ þ mouse has been used extensively demonstrated by the recognition that mutations in the to characterize the response to potential therapeutic adenomatous polyposis coli gene (APC) underlie familial strategies, and a comprehensive list of the effects of 269 chemopreventative agents has been assem- Correspondence: Professor AR Clarke, Cardiff School of Biosciences, bled at http://www.inra.fr/reseau-nacre/sci-memb/corpet/ Museum Avenue, Cardiff University, Cardiff, CF10 3US, UK. indexan.html (Corpet and Pierre, 2003). The pertinent E-mail: [email protected] question arising from these studies is the extent to which Wnt signalling in the mouse intestine AR Clarke 7513 these results relate to human disease. By virtue of the downregulation of b-catenin. The ‘just right’ model sheer number of studies performed in the ApcMin/ þ implies that different Apc mutations result in different mouse, it is becoming possible to address this question, levels of pathway activation and thereby differing although there remain immense technical difficulties in degrees of tumour susceptibility. This strongly argues direct mouse/man comparisons. It is therefore encoura- that not all Apc mutations are equivalent, a conclusion ging that a meta-analysis of chemopreventative agents which also follows from the multifunctional nature of Apc, used in mouse and human has shown relatively good and which is supported by the phenotypes of mice bearing correspondence for a number of agents, such as sulindac different mutations in Apc. Compared to the ApcMin/ þ (Corpet and Pierre, 2005). Further encouragement that mutation, mice bearing an earlier truncation (at codon the ApcMin/ þ mouse is truly relevant to human disease 716) develop higher numbers of polyps (Oshima et al., derives from the observation that expression of the 1995), whereas mice heterozygous for the later 1638N modifier Pla2g2a significantly correlates with survival chain terminating mutation have an attenuated phenotype for patients with gastric adenocarcinoma (Leung et al., relative to the ApcMin/ þ mouse (Smits et al., 1997). The 2002). Microarray studies also argue in favour of direct 1638N mice develop five to six adenomas of the small human relevance of the ApcMin/ þ mouse, with trans- intestine during the first 6 months of life, and have also criptional profiles derived from the mouse successfully been reported to develop aberrant crypt foci in the colon identifying novel gene targets in human colorectal that retain Apc protein, suggesting heterozygosity for this tumours (Reichling et al., 2005). mutation is sufficient to initiate lesion development Somewhat fewer studies have been reported assessing (Pretlow et al., 2003). Finally, mice have been constructed genetic modification of the ApcMin phenotype, however bearing hypomorphic alleles wherein expression of Apc is this still represents a substantial and growing database reduced to 20 and 10% of wild-type levels and polyp of genetic backgrounds known to accelerate or suppress formation is reduced compared to the 716 mutation (Li tumorigenesis. For example, deficiency of many DNA et al., 2005). These hypomorphic alleles are characterized repair proteins accelerates polyp formation including by levels of b-catenin expression that inversely correlate the mismatch repair proteins (e.g. Reitmair et al., 1996), with Apc levels, and have been used to argue for a the thymidine glycosylase Mbd4 (Millar et al., 2002), threshold level of Apc (15% of wild type) at which a single and the base excision repair gene Myh (Sieber et al., polyp will develop per mouse (Li et al., 2005). 2004). In terms of the Wnt pathway, both heterozygosity and complete deficiency of the proposed Wnt target gene cyclin D1 have been shown to suppress adenoma The primary consequences of inactivation of Apc: formation, although adenomas do still develop in the conditional models absence of cyclin D1 (Wilding et al., 2002;Hulit et al., The development of the different constitutive Apc 2004). Indeed, the status of cyclin D1 as a Wnt target is mutants has greatly advanced our understanding of somewhat debatable, as it appears not to be an the subtleties of altered Wnt signalling upon adenoma immediate target of the Wnt pathway in vivo, becoming formation. However, these models have shed rela- deregulated in a delayed manner in a subset of tively little light on the precise mechanisms through Wnt-activated cells (Sansom et al., 2005). For another which Wnt activation leads to adenoma initiation. This proposed target, peroxisome proliferator-activated difficulty has been at least partially circumvented by receptor (PPAR)-delta, the story is also rather unclear. the development of strategies to conditionally in- In this case, both activation and inactivation of this activate Apc within the adult intestinal epithelium. pathway have been shown to accelerate intestinal Two approaches have been used to achieve this, based tumour formation in the ApcMin/ þ mice, albeit to on the use of a loxP-flanked Apc allele in conjunction differing extents (Gupta et al., 2004, Harman et al., with either an inducible Cyp1A-Cre transgene (Sansom 2004, Reed et al., 2004). The interpretation here must be et al., 2003) or a tamoxifen regulable, intestinal-specific that activation of PPAR-delta accelerates neoplasia, Villin-CreER transgene (Andreu et al., 2005). The but that this is not a relevant mechanism to normal phenotypes reported by both systems are remarkably adenoma formation in the ApcMin/ þ mouse. These rather similar. Inactivation of Apc leads to the rapid reloca- complex results for both cyclin D1 and PPAR-delta lization of b-catenin to the nucleus and rapid changes in underline the necessity of for validating proposed Wnt both the appearance of enterocytes and in the gross targets and Wnt-dependent mechanisms in an appro- histology of the crypt. Cell movement within the crypt is priate in vivo setting.
Recommended publications
  • Identification of a WNT5A-Responsive Degradation Domain in the Kinesin
    G C A T T A C G G C A T genes Article Identification of a WNT5A-Responsive Degradation Domain in the Kinesin Superfamily Protein KIF26B Edith P. Karuna ID , Shannon S. Choi, Michael K. Scales, Jennie Hum, Michael Cohen, Fernando A. Fierro and Hsin-Yi Henry Ho * ID Department of Cell Biology and Human Anatomy, School of Medicine, University of California, Davis, CA 95616, USA; [email protected] (E.P.K.); [email protected] (S.S.C.); [email protected] (M.K.S.); [email protected] (J.H.); [email protected] (M.C.); ffi[email protected] (F.A.F.) * Correspondence: [email protected]; Tel.: +1-530-752-8857 Received: 19 February 2018; Accepted: 26 March 2018; Published: 5 April 2018 Abstract: Noncanonical WNT pathways function independently of the β-catenin transcriptional co-activator to regulate diverse morphogenetic and pathogenic processes. Recent studies showed that noncanonical WNTs, such as WNT5A, can signal the degradation of several downstream effectors, thereby modulating these effectors’ cellular activities. The protein domain(s) that mediates the WNT5A-dependent degradation response, however, has not been identified. By coupling protein mutagenesis experiments with a flow cytometry-based degradation reporter assay, we have defined a protein domain in the kinesin superfamily protein KIF26B that is essential for WNT5A-dependent degradation. We found that a human disease-causing KIF26B mutation located at a conserved amino acid within this domain compromises the ability of WNT5A to induce KIF26B degradation. Using pharmacological perturbation, we further uncovered a role of glycogen synthase kinase 3 (GSK3) in WNT5A regulation of KIF26B degradation.
    [Show full text]
  • Genetic Variants in WNT2B and BTRC Predict Melanoma Survival
    ACCEPTED MANUSCRIPT Genetic Variants in WNT2B and BTRC Predict Melanoma Survival Qiong Shi1, 2, 3, 9, Hongliang Liu2, 3, 9, Peng Han2, 3, 4, 9, Chunying Li1, Yanru Wang2, 3, Wenting Wu5, Dakai Zhu6, Christopher I. Amos6, Shenying Fang7, Jeffrey E. Lee7, Jiali Han5, 8* and Qingyi Wei2, 3* 1Department of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi’an, Shaanxi 710032, China; 2Duke Cancer Institute, Duke University Medical Center, Durham, NC 27710, USA, 3Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA, 4Department of Otorhinolaryngology Head and Neck Surgery, First Affiliated Hospital, Xi'an Jiaotong University College of Medicine, Xi'an, Shaanxi 710061, China; 5Department of Epidemiology, Fairbanks School of Public Health, Indiana University Melvin and Bren Simon Cancer Center, Indiana University, Indianapolis,MANUSCRIPT IN 46202, USA 6Community and Family Medicine, Geisel School of Medicine, Dartmouth College, Hanover, NH 03755, USA; 7Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. 8Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital, Boston, MA 02115, USA 9These authors contributed equally to this work. ACCEPTED *Correspondence: Qingyi Wei, M.D., Ph.D., Duke Cancer Institute, Duke University Medical Center and Department of Medicine, Duke School of Medicine, 905 S LaSalle Street, Durham, NC 27710, USA, Tel.: (919) 660-0562, E-mail: [email protected] and Jiali Han, M.D., Ph.D., 1 _________________________________________________________________________________ This is the author's manuscript of the article published in final edited form as: Shi, Q., Liu, H., Han, P., Li, C., Wang, Y., Wu, W., … Wei, Q.
    [Show full text]
  • The Wnt Signaling Pathway in Tumorigenesis, Pharmacological
    Wang et al. Biomarker Research (2021) 9:68 https://doi.org/10.1186/s40364-021-00323-7 REVIEW Open Access The Wnt signaling pathway in tumorigenesis, pharmacological targets, and drug development for cancer therapy Zhuo Wang1,2†, Tingting Zhao1,2†, Shihui Zhang3, Junkai Wang1, Yunyun Chen1,2, Hongzhou Zhao1,2, Yaxin Yang4, Songlin Shi2, Qiang Chen5 and Kuancan Liu1,2* Abstract Wnt signaling was initially recognized to be vital for tissue development and homeostasis maintenance. Further studies revealed that this pathway is also important for tumorigenesis and progression. Abnormal expression of signaling components through gene mutation or epigenetic regulation is closely associated with tumor progression and poor prognosis in several tissues. Additionally, Wnt signaling also influences the tumor microenvironment and immune response. Some strategies and drugs have been proposed to target this pathway, such as blocking receptors/ligands, targeting intracellular molecules, beta-catenin/TCF4 complex and its downstream target genes, or tumor microenvironment and immune response. Here we discuss the roles of these components in Wnt signaling pathway in tumorigenesis and cancer progression, the underlying mechanisms that is responsible for the activation of Wnt signaling, and a series of drugs targeting the Wnt pathway provide multiple therapeutic values. Although some of these drugs exhibit exciting anti-cancer effect, clinical trials and systematic evaluation should be strictly performed along with multiple-omics technology. Keywords: Wnt signaling, beta-catenin, Epigenetic modification, Tumor microenvironment, Drug development Background polyposis coli (APC), glycogen synthase kinase-3β (GSK- The Wnt signaling cascade is critical for tissue morpho- 3β), Axin, casein kinase 1(CK1). Degradation of beta- genesis, homeostasis, and regeneration.
    [Show full text]
  • Expression of Wnt5a and Wnt10b in Non-Immortalized Breast Cancer Cells
    903-907 24/2/07 13:56 Page 903 ONCOLOGY REPORTS 17: 903-907, 2007 903 Expression of Wnt5A and Wnt10B in non-immortalized breast cancer cells MARIANA FERNANDEZ-COBO1, FRANCESCA ZAMMARCHI3, JOHN MANDELI4, JAMES F. HOLLAND1 and BEATRIZ G.T. POGO1,2 Departments of 1Medicine, 2Microbiology and Community, and 4Preventive Medicine, Mount Sinai School of Medicine; 3Department of Molecular Pharmacology and Chemistry, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA Received October 23, 2006; Accepted November 7, 2006 Abstract. Wnt signaling is usually divided into two path- transcriptional factors of the LEF/TCF family and the TCF/ ways: the ‘canonical’, acting through ß-catenin, and the ‘non- ß-catenin complexes regulate expression of specific target canonical’ acting through the Ca2+ and planar cell polarity genes. In the non-canonical pathway there are mainly two alter- pathway. Both pathways have been implicated in different native ways of Wnt signaling which do not involve ß-catenin: types of cancer. Most results obtained with established cell the Wnt/Ca2+ pathway, which acts via calmodulin kinase II and lines have been contradictory. Here, we have investigated the protein kinase C, and the planar cell polarity pathway, which expression of Wnt10B (canonical) and Wnt5A (non-canonical) controls cytoskeletal rearrangements through Jun N-terminal in a panel of finite life-span and established normal and kinase (2). breast cancer cells using quantitative RT-PCR. It was found The role of Wnt genes in breast cancer has been studied that there were both significant overexpression of Wnt5A and since 1982, when the first Wnt member (called int-1) was underexpression of Wnt10B in the metastasis-derived finite identified as the gene activated by integration of the mouse life-span breast cancer cells when they were compared to the mammary tumor virus, resulting in the development of finite life-span normal and established normal and breast mammary tumors in mice (3).
    [Show full text]
  • A Commentary on WNT7A Implication in Cervical Cancer Development
    ndrom Sy es tic & e G n e e n G e f T o Artaza-Irigaray et al., J Genet Syndr Gene Ther 2015, 6:3 Journal of Genetic Syndromes h l e a r n a DOI: 10.4172/2157-7412.1000267 r p u y o J & Gene Therapy ISSN: 2157-7412 Commentary Open Access A Commentary on WNT7A Implication in Cervical Cancer Development Cristina Artaza-Irigaray1,2, Adriana Aguilar-Lemarroy1 and Luis F Jave-Suárez1* 1División de Inmunología, Centro de Investigación Biomédica de Occidente (CIBO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara, Jalisco, Mexico 2Programa de Doctorado en Ciencias Biomédicas, Centro Universitario de Ciencias de la Salud (CUCS) - Universidad de Guadalajara, Jalisco, Mexico Cervical Cancer (CC) is the fourth leading cause of cancer Conversely, silencing Wnt7a in HaCaT cells induced an increase in cell deaths in women worldwide and is associated directly with Human proliferation and migration rates. These results suggest that the loss of papillomavirus (HPV) infection [1]. Many authors have reported Wnt7a expression probably contributes to increased cell proliferation that HPV can immortalize human cells without leading to cell and migration during cervical tumor development. transformation by itself [2,3]. Thus, cervical carcinogenesis is a As responses always lead to new questions, the next step was multistep process involving HPV infection and additional alterations. to elucidate the way in which Wnt7a ligand expression was being In 2005, canonical Wnt signaling pathway activation was proposed repressed. Wnt7a is known to possess tumor suppressor properties as a second hit during epithelial malignant transformation but this in several cancers and is frequently inactivated due to CpG-island hypothesis remains controversial [3,4].
    [Show full text]
  • WNT11-Conditioned Medium Promotes Angiogenesis Through the Activation of Non-Canonical WNT-PKC-JNK Signaling Pathway
    G C A T T A C G G C A T genes Article WNT11-Conditioned Medium Promotes Angiogenesis through the Activation of Non-Canonical WNT-PKC-JNK Signaling Pathway § Jingcai Wang y, Min Gong z, Shi Zuo , Jie Xu, Chris Paul, Hongxia Li k, Min Liu, Yi-Gang Wang, Muhammad Ashraf ¶ and Meifeng Xu * Department of Pathology and Laboratory Medicine, University of Cincinnati Medical Center, Cincinnati, OH 45267, USA; [email protected] (J.W.); [email protected] (M.G.); [email protected] (S.Z.); [email protected] (J.X.); [email protected] (C.P.); [email protected] (H.L.); [email protected] (M.L.); [email protected] (Y.-G.W.); [email protected] (M.A.) * Correspondence: [email protected] Current address: Department of Pathology and Laboratory Medicine, Nationwide Children’s Hospital, y Columbus, OH 43205, USA. Current Address: Department of Neonatology, Children’s Hospital of Soochow University, z Suzhou 215025, Jiangsu, China. § Current Address: Department of Hepatobiliary Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang 550025, Guizhou, China. Current Address: Department of Cardiology, The First Affiliated Hospital of Soochow University, k Suzhou 215006, Jiangsu, China. ¶ Current Address: Department of Medicine, Cardiology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA. Received: 10 August 2020; Accepted: 26 October 2020; Published: 29 October 2020 Abstract: Background: We demonstrated that the transduction of Wnt11 into mesenchymal stem cells (MSCs) (MSCWnt11) promotes these cells differentiation into cardiac phenotypes. In the present study, we investigated the paracrine effects of MSCWnt11 on cardiac function and angiogenesis.
    [Show full text]
  • Theranostics WNT6 Is a Novel Oncogenic Prognostic Biomarker In
    Theranostics 2018, Vol. 8, Issue 17 4805 Ivyspring International Publisher Theranostics 2018; 8(17): 4805-4823. doi: 10.7150/thno.25025 Research Paper WNT6 is a novel oncogenic prognostic biomarker in human glioblastoma Céline S. Gonçalves1,2, Joana Vieira de Castro1,2, Marta Pojo1,2, Eduarda P. Martins1,2, Sandro Queirós1,2, Emmanuel Chautard3,4, Ricardo Taipa5, Manuel Melo Pires5, Afonso A. Pinto6, Fernando Pardal7, Carlos Custódia8, Cláudia C. Faria8,9, Carlos Clara10, Rui M. Reis1,2,10, Nuno Sousa1,2, Bruno M. Costa1,2 1. Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus Gualtar, 4710-057 Braga, Portugal 2. ICVS/3B’s - PT Government Associate Laboratory, Braga/Guimarães, Portugal 3. Université Clermont Auvergne, INSERM, U1240 IMoST, 63000 Clermont Ferrand, France 4. Pathology Department, Université Clermont Auvergne, Centre Jean Perrin, 63011 Clermont-Ferrand, France 5. Neuropathology Unit, Department of Neurosciences, Centro Hospitalar do Porto, Porto, Portugal 6. Department of Neurosurgery, Hospital Escala Braga, Sete Fontes - São Victor 4710-243 Braga, Portugal 7. Department of Pathology, Hospital Escala Braga, Sete Fontes - São Victor 4710-243 Braga, Portugal 8. Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal 9. Neurosurgery Department, Hospital de Santa Maria, Centro Hospitalar Lisboa Norte (CHLN), Lisbon, Portugal 10. Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos - S. Paulo, Brazil. Corresponding author: Bruno M. Costa, Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal. Email: [email protected]; Phone: (+351)253604837; Fax: (+351)253604831 © Ivyspring International Publisher.
    [Show full text]
  • Wnt-Independent and Wnt-Dependent Effects of APC Loss on the Chemotherapeutic Response
    International Journal of Molecular Sciences Review Wnt-Independent and Wnt-Dependent Effects of APC Loss on the Chemotherapeutic Response Casey D. Stefanski 1,2 and Jenifer R. Prosperi 1,2,3,* 1 Department of Biological Sciences, University of Notre Dame, Notre Dame, IN 46617, USA; [email protected] 2 Mike and Josie Harper Cancer Research Institute, South Bend, IN 46617, USA 3 Department of Biochemistry and Molecular Biology, Indiana University School of Medicine-South Bend, South Bend, IN 46617, USA * Correspondence: [email protected]; Tel.: +1-574-631-4002 Received: 30 September 2020; Accepted: 20 October 2020; Published: 22 October 2020 Abstract: Resistance to chemotherapy occurs through mechanisms within the epithelial tumor cells or through interactions with components of the tumor microenvironment (TME). Chemoresistance and the development of recurrent tumors are two of the leading factors of cancer-related deaths. The Adenomatous Polyposis Coli (APC) tumor suppressor is lost in many different cancers, including colorectal, breast, and prostate cancer, and its loss correlates with a decreased overall survival in cancer patients. While APC is commonly known for its role as a negative regulator of the WNT pathway, APC has numerous binding partners and functional roles. Through APC’s interactions with DNA repair proteins, DNA replication proteins, tubulin, and other components, recent evidence has shown that APC regulates the chemotherapy response in cancer cells. In this review article, we provide an overview of some of the cellular processes in which APC participates and how they impact chemoresistance through both epithelial- and TME-derived mechanisms. Keywords: adenomatous polyposis coli; chemoresistance; WNT signaling 1.
    [Show full text]
  • Evolutionarily Conserved Tbx5–Wnt2/2B Pathway Orchestrates Cardiopulmonary Development
    Evolutionarily conserved Tbx5–Wnt2/2b pathway orchestrates cardiopulmonary development Jeffrey D. Steimlea,b,c, Scott A. Rankind,e,f,g, Christopher E. Slagleh,i,j,k, Jenna Bekenya,b,c, Ariel B. Rydeena,b,c, Sunny Sun-Kin Chanl,m, Junghun Kweona,b,c, Xinan H. Yanga,b,c, Kohta Ikegamia,b,c, Rangarajan D. Nadadura,b,c, Megan Rowtona,b,c, Andrew D. Hoffmanna,b,c, Sonja Lazarevica,b,c, William Thomasn,o, Erin A. T. Boyle Andersonp, Marko E. Horbn,o, Luis Luna-Zuritaq,r, Robert K. Hom, Michael Kybal,m, Bjarke Jensens, Aaron M. Zornd,e,f,g, Frank L. Conlonh,i,j,k, and Ivan P. Moskowitza,b,c,1 aDepartment of Pediatrics, University of Chicago, Chicago, IL 60637; bDepartment of Pathology, University of Chicago, Chicago, IL 60637; cDepartment of Human Genetics, University of Chicago, Chicago, IL 60637; dCenter for Stem Cell and Organoid Medicine, Cincinnati Children’s Research Foundation, Cincinnati, OH 45229; eDepartment of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, OH 45229; fDivision of Developmental Biology, Perinatal Institute, Cincinnati Children’s Research Foundation, Cincinnati Children’s Hospital Medical Center, University of Cincinnati, Cincinnati, OH 45229; gDepartment of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, OH 45229; hDepartment of Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599; iDepartment of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599; jIntegrative Program for Biological and Genome Sciences, University of North
    [Show full text]
  • Wnt11 Regulates Cardiac Chamber Development and Disease During Perinatal Maturation
    Wnt11 regulates cardiac chamber development and disease during perinatal maturation Marlin Touma, … , Brian Reemtsen, Yibin Wang JCI Insight. 2017;2(17):e94904. https://doi.org/10.1172/jci.insight.94904. Research Article Cardiology Genetics Ventricular chamber growth and development during perinatal circulatory transition is critical for functional adaptation of the heart. However, the chamber-specific programs of neonatal heart growth are poorly understood. We used integrated systems genomic and functional biology analyses of the perinatal chamber specific transcriptome and we identified Wnt11 as a prominent regulator of chamber-specific proliferation. Importantly, downregulation of Wnt11 expression was associated with cyanotic congenital heart defect (CHD) phenotypes and correlated with O2 saturation levels in hypoxemic infants with Tetralogy of Fallot (TOF). Perinatal hypoxia treatment in mice suppressed Wnt11 expression and induced myocyte proliferation more robustly in the right ventricle, modulating Rb1 protein activity. Wnt11 inactivation was sufficient to induce myocyte proliferation in perinatal mouse hearts and reduced Rb1 protein and phosphorylation in neonatal cardiomyocytes. Finally, downregulated Wnt11 in hypoxemic TOF infantile hearts was associated with Rb1 suppression and induction of proliferation markers. This study revealed a previously uncharacterized function of Wnt11-mediated signaling as an important player in programming the chamber-specific growth of the neonatal heart. This function influences the chamber-specific development and pathogenesis in response to hypoxia and cyanotic CHDs. Defining the underlying regulatory mechanism may yield chamber-specific therapies for infants born with CHDs. Find the latest version: https://jci.me/94904/pdf RESEARCH ARTICLE Wnt11 regulates cardiac chamber development and disease during perinatal maturation Marlin Touma,1,2 Xuedong Kang,1,2 Fuying Gao,3 Yan Zhao,1,2 Ashley A.
    [Show full text]
  • Wnt11 and Ret/Gdnf Pathways Cooperate in Regulating Ureteric Branching During Metanephric Kidney Development
    Development 130, 3175-3185 3175 © 2003 The Company of Biologists Ltd doi:10.1242/dev.00520 Wnt11 and Ret/Gdnf pathways cooperate in regulating ureteric branching during metanephric kidney development Arindam Majumdar1, Seppo Vainio2, Andreas Kispert3, Jill McMahon1 and Andrew P. McMahon1,* 1Department of Molecular and Cellular Biology, Harvard University, 16 Divinity Avenue, Cambridge, MA 02138, USA 2Biocenter Oulu and Department of Biochemistry, Faculties of Science and Medicine, University of Oulu, FIN-90014, Oulu, Finland 3Institut für Molekularbiologie, OE5250, Medizinische Hochschule Hannover, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany *Author for correspondence (e-mail: [email protected]) Accepted 1 April 2003 SUMMARY Reciprocal cell-cell interactions between the ureteric (Gdnf). Gdnf encodes a mesenchymally produced ligand for epithelium and the metanephric mesenchyme are needed to the Ret tyrosine kinase receptor that is crucial for normal drive growth and differentiation of the embryonic kidney to ureteric branching. Conversely, Wnt11 expression is completion. Branching morphogenesis of the Wolffian duct reduced in the absence of Ret/Gdnf signaling. Consistent derived ureteric bud is integral in the generation of ureteric with the idea that reciprocal interaction between Wnt11 and tips and the elaboration of the collecting duct system. Ret/Gdnf regulates the branching process, Wnt11 and Ret Wnt11, a member of the Wnt superfamily of secreted mutations synergistically interact in ureteric branching glycoproteins, which
    [Show full text]
  • Tsukushi Functions As a Wnt Signaling Inhibitor by Competing with Wnt2b for Binding to Transmembrane Protein Frizzled4
    Tsukushi functions as a Wnt signaling inhibitor by competing with Wnt2b for binding to transmembrane protein Frizzled4 Kunimasa Ohtaa,b,1,2, Ayako Itoa,c,1, Sei Kuriyamaa,d,3, Giuseppe Lupoe,f, Mitsuko Kosakag,4, Shin-ichi Ohnumah, Shinichi Nakagawai, and Hideaki Tanakaa,c,d aDepartment of Developmental Neurobiology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-8556, Japan; bPrecursory Research for Embryonic Science and Technology, Japan Science and Technology Agency, Saitama 332-0012, Japan; cGlobal Center of Excellence, Kumamoto University, Kumamoto 860-8556, Japan; d21st Century Center of Excellence, Kumamoto University, Kumamoto 860-8556, Japan; eDepartment of Biology and Biotechnology “C. Darwin,” University of Rome “La Sapienza,” 00185 Rome, Italy; fIstituto Pasteur–Fondazione Cenci Bolognetti, 00185, Rome, Italy; gRIKEN Center for Developmental Biology, Kobe 650-0047, Japan; hInstitute of Ophthalmology, University College London, London EC1V 9EL, United Kingdom; and IRIKEN Advanced Science Institute, Nakagawa RNA Biology Laboratory, Saitama 351-0198, Japan Edited* by Lynn T. Landmesser, Case Western Reserve University, Cleveland, OH, and approved July 8, 2011 (received for review January 11, 2011) The Wnt signaling pathway is essential for the development of We previously described the isolation of Tsukushi (TSK) protein diverse tissues during embryogenesis. Signal transduction is acti- isoforms (13), soluble molecules belonging to the small leucine- vated by the binding of Wnt proteins to the type I receptor low- rich proteoglycan (SLRP) family (14), and showed that they work density lipoprotein receptor–related protein 5/6 and the seven-pass as extracellular modulators of pivotal signaling cascades during transmembrane protein Frizzled (Fzd), which contains a Wnt- early embryonic development in chicks and frogs (13, 15–17).
    [Show full text]